Verhagen, N. B., Koerber, N. K., Szabo, A., Taylor, B., Wainaina, J. N., Evans, D. B., … N3C Consortium. (2023). Vaccination Against SARS-CoV-2 Decreases Risk of Adverse Events in Patients who Develop COVID-19 Following Cancer Surgery. Ann Surg Oncol, 30(3), 1305–1308. https://doi.org/10.1245/s10434-022-12916-z

Verhagen, Nathaniel B., Nicolas K. Koerber, Aniko Szabo, Bradley Taylor, J Njeri Wainaina, Douglas B. Evans, Anai N. Kothari, and N3C Consortium. “Vaccination Against SARS-CoV-2 Decreases Risk of Adverse Events in Patients who Develop COVID-19 Following Cancer Surgery.” Ann Surg Oncol 30, no. 3 (March 2023): 1305–8. https://doi.org/10.1245/s10434-022-12916-z.

Verhagen NB, Koerber NK, Szabo A, Taylor B, Wainaina JN, Evans DB, et al. Vaccination Against SARS-CoV-2 Decreases Risk of Adverse Events in Patients who Develop COVID-19 Following Cancer Surgery. Ann Surg Oncol. 2023 Mar;30(3):1305–8.

Verhagen, Nathaniel B., et al. “Vaccination Against SARS-CoV-2 Decreases Risk of Adverse Events in Patients who Develop COVID-19 Following Cancer Surgery.” Ann Surg Oncol, vol. 30, no. 3, Mar. 2023, pp. 1305–08. Pubmed, doi:10.1245/s10434-022-12916-z.

Verhagen NB, Koerber NK, Szabo A, Taylor B, Wainaina JN, Evans DB, Kothari AN, N3C Consortium. Vaccination Against SARS-CoV-2 Decreases Risk of Adverse Events in Patients who Develop COVID-19 Following Cancer Surgery. Ann Surg Oncol. 2023 Mar;30(3):1305–1308.